{
  "docId": "019de071-070c-73b2-9571-237f2cba3dac",
  "docSlug": "eaf4652b86f0ff99a8c8d1e4248b3852",
  "documentTitle": "Genetron | Results Presentation Deck | 25 slides",
  "authorId": "genetron",
  "authorName": "Genetron",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 25,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The slide uses a pie chart to segment the TAM, with supporting text boxes detailing market leadership and operational metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-070c-73b2-9571-237f2cba3dac/3",
  "deckHref": "/decks/019de071-070c-73b2-9571-237f2cba3dac",
  "deckJsonHref": "/decks/019de071-070c-73b2-9571-237f2cba3dac.json",
  "deckAnchorHref": "/decks/019de071-070c-73b2-9571-237f2cba3dac#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.41,
        "y": 0.35
      },
      "kind": "chart",
      "text": "TAM segmentation by business unit",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef9d2674-1758-438c-92a6-77a067aa59f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.805,
        "y": 0.05
      },
      "kind": "image",
      "text": "GENETRON",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a97413d2-aa75-4ef4-8e1a-72127ea4443d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.23,
        "y": 0.21
      },
      "kind": "list",
      "text": "One-step Seq, Mutation Capsules, FusionScan",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "744cf4ab-225e-4e73-ab2b-a5eafefe2d99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.18,
        "x": 0.23,
        "y": 0.5
      },
      "kind": "paragraph",
      "text": "#1 in China for Biopharma Partners, ~40 Total Biopharma Partners",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "395d3fad-17d9-4af0-824c-4e30fcf2e783",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.7,
        "y": 0.42
      },
      "kind": "paragraph",
      "text": "#1 in China for IVD approved products, Top 3 in China for LDT Revenue, 7 Products in Pipeline, 2-day TAT for S5+Lung 8, 1st Published Liver Cancer Prospective Study",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad77bda8-d0b6-431d-9aca-6b3146a59da6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.22,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Source: Frost & Sullivan (1) Market potential as of 2023",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69c9dced-e267-4001-8c79-41040cfb9c14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "China's leading precision oncology company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d1b5007-5df7-4c4b-a368-169bd6276aaf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "68d7b583-c797-439d-b07c-231b04dfe136",
      "evidence": "This slide presents a brief overview of Genetron Holdings Limited's achievements and goals.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 3,
      "beatId": "1586172e-b6e1-4201-ac9b-fdd230e374d9",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The presentation deck starts with an overview of Genetron's business and recent events",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}